Maged Shenouda, CFO at RELMADA THERAPEUTICS, INC. (RLMD), sold 2,856 shares at $35.39 ($101K) on 2021-02-11, disclosed to the SEC on 2021-02-16.
Open-market sale of $101k RLMD by CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.39 | 1,428 | $51K | 50.0% |
| 2 | $35.39 | 1,428 | $51K | 50.0% |
| Total | $35.39 avg | 2,856 | $101K | 100% |
| Filing → |
| RLMD | BUY | 2025-11-06 | $1.1M | — | Filing → |
| RLMD | BUY | 2025-05-20 | $97K | — | Filing → |
| RLMD | BUY | 2024-09-11 | $207K | — | Filing → |